BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12134647)

  • 1. [Prostanoids and acute lung injury].
    Kudoh I; Ohara M; Sawa T
    Masui; 2002 Jun; 51(6):598-604. PubMed ID: 12134647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current topics in the regulation of prostanoids-1. Inducible cyclooxygenase COX-2 and selective blockers].
    Ohara M; Sawa T
    Masui; 1998 Nov; 47(11):1325-32. PubMed ID: 9852696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COX-1 and COX-2 inhibition: current status and future perspective.
    Greyn J; Lauwers MH; Vanlersberghe C; Camu F
    Acta Anaesthesiol Belg; 1998; 49(3):175-83. PubMed ID: 9844704
    [No Abstract]   [Full Text] [Related]  

  • 4. COX-2 inhibitor as a radiation enhancer: new strategies for the treatment of lung cancer.
    Saha D; Pyo H; Choy H
    Am J Clin Oncol; 2003 Aug; 26(4):S70-4. PubMed ID: 12902860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
    Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
    In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COX-2: a target for prevention and treatment of esophageal cancer.
    Altorki N
    J Surg Res; 2004 Mar; 117(1):114-20. PubMed ID: 15013721
    [No Abstract]   [Full Text] [Related]  

  • 7. [COX-2 expression in gastric cancers].
    Sakamoto C
    Nihon Rinsho; 2001 Apr; 59 Suppl 4():598-603. PubMed ID: 11424449
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical pharmacology of selective inhibitors of cyclooxygenase-2].
    Patrignani P
    Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):13-8, 37-40. PubMed ID: 15058604
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclooxygenase-2 (COX-2) enzyme inhibitors and radiotherapy: preclinical basis.
    Milas L
    Am J Clin Oncol; 2003 Aug; 26(4):S66-9. PubMed ID: 12902859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2) inhibitors: indications and complications.
    Pascucci RA
    J Am Osteopath Assoc; 2002 Sep; 102(9):487-9. PubMed ID: 12361181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of breast cancer by targeting cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma (Review).
    Badawi AF; Badr MZ
    Int J Oncol; 2002 Jun; 20(6):1109-22. PubMed ID: 12011987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cyclooxygenases in the spinal cord and the relationship with pain].
    Li SQ; Li WB
    Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):359-60. PubMed ID: 14992024
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical pharmacology of selective COX-2 inhibitors.
    Capone ML; Tacconelli S; Sciulli MG; Patrignani P
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):49-58. PubMed ID: 14552704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Physiopathological and therapeutic study of collagen diseases based on results of clinical tests--role of prostaglandins].
    Sano H
    Nihon Naika Gakkai Zasshi; 1998 Dec; 87(12):2438-45. PubMed ID: 9922664
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review.
    Pruthi RS; Derksen E; Gaston K
    J Urol; 2003 Jun; 169(6):2352-9. PubMed ID: 12771797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Colorectal cancer and inhibition of cyclooxygenase-2].
    Geissler M; Mohr L; Blum HE
    Dtsch Med Wochenschr; 2002 Jun; 127(23):1256-8. PubMed ID: 12053285
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors.
    Kusunoki N; Yamazaki R; Kawai S
    Arthritis Rheum; 2002 Dec; 46(12):3159-67. PubMed ID: 12483719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cyclo-oxygenase 2 inhibitors and cancer].
    André T; Soria JC
    Bull Cancer; 2004 May; 91 Spec No():S59-60. PubMed ID: 15239332
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy, safety and potential clinical roles of the COX-2-specific inhibitors.
    van der Bijl P; van der Bijl P
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):17-22. PubMed ID: 14552700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current status of study on selective cyclooxygenase-2 inhibitors and evaluation of its application].
    He W; Liu CF; Huang CQ
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):184-6. PubMed ID: 12390825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.